Campylobacter bacteremia: Clinical characteristics, incidence, and outcome over 23 years

Medicine

Volumn 89, Issue 5, 2010, Pages 319-330

  Fernández Cruz, Ana ^a   Muñoz, Patricia ^a,c   Mohedano, Rosa ^a,b   Valerio, Maricela ^a,c   Marín, Mercedes ^a   Alcalá, Luis ^a,c   Rodriguez Créixems, Marta ^a,c   Cercenado, Emilia ^a,c   Bouza, Emilio ^a,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIRETROVIRUS AGENT; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN; RIBOSOME RNA;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER FETUS; CAMPYLOBACTER JEJUNI; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; STRAIN DIFFERENCE; ADOLESCENT; CAMPYLOBACTER INFECTIONS; CASE REPORT; CHILD; GENETIC PREDISPOSITION; GENETICS; HEALTH STATUS; HIV INFECTIONS; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAMPYLOBACTER INFECTIONS; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, RIBOSOMAL; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957273787     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181f2638d     Document Type: Article

References (70)

1. Barros-Velazquez J, Jimenez A, Villa TG. Isolation and typing methods for the epidemiologic investigation of thermotolerant campylobacters. Int Microbiol. 1999;2:217-226.
2. Behl D, Manchanda R, Thomas C. Camplyobacter empyema due to food aspiration. JHosp Med. 2008;3:81-83.
3. Blaser MJ. Campylobacter fetus\emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin Infect Dis. 1998;27:256-258.
4. Blaser MJ. Extraintestinal Campylobacter infections. West J Med. 1986;144:353-354.
5. Bourke B, Chan VL, Sherman P. Campylobacter upsaliensis: waiting in the wings. Clin Microbiol Rev. 1998;11:440-449.
6. Brunel V, Allegre T, Cailleres S, Blanc AP. [Hematologic manifestations in Campylobacter coli septicemia. Apropos of a case]. Rev Med Interne. 1993;14:39-40.
7. Butzler JP Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004;10:868-876.
8. Callahan C, Greene JN, Sandin RL, Ruge D, Johnson J. Campylobacter jejuni bacteremia in an HIV-positive patient with non-Hodgkin's lymphoma. Cancer Control. 1998;5:357-360.
9. Carnahan AM, Beadling J, Watsky D, Ford N. Detection of Campylobacter upsaliensis from a blood culture by using the BacT/Alert system. J Clin Microbiol. 1994;32:2598-2599.
10. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline. Wayne PA: Clinical and Laboratory Standards Institute; 2007.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Wayne PA: Clinical and Laboratory Standards Institute. M-100-S19; 29 (3, January Informational Supplement); 2009.
12. Chua K, Gurtler V, Montgomery J, Fraenkel M, Mayall BC, Grayson ML. Campylobacter insulaenigrae causing septicaemia and enteritis. J Med Microbiol. 2007;56:1565-1567.
13. Chuman Y, Takata T, Sameshima H, Takeuchi S, Takatsuka Y, Makino T, Blaser MJ, Utsunomiya A. Campylobacter fetus bacteremia in a patient with adult T cell leukemia. Clin Infect Dis. 2003;36: 1497-1498.
14. Conde Martel A, Suarez Ortega S, Campos-Herrero Navas MI, Elcuaz Romano R. [Campylobacter fetus sepsis, pulmonary thromboembolism and an occult neoplasm]. An Med Interna. 1999;16:103.
15. Dingle KE, Clarke L, Bowler IC. Ciprofloxacin resistance among human Campylobacter isolates 1991-2004: an update. JAntimicrob Chemother. 2005;56:435-437.
16. Drancourt M, Berger P, Raoult D. Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol. 2004;42: 2197-2202.
17. Epifane G, Barbon S, Sadino G, Bouchet D, Suarez ME, Mangiaterra S. EBacteremia due to Campylobacter fetus isolated by conventional methods from an immunocompromised patient. Rev Argent Microbiol. 2007;39:34-37.
18. Fearnley C, Manning G, Bagnall M, Javed MA, Wassenaar TM, Newell DG. Identification of hyperinvasive Campylobacter jejuni strains isolated from poultry and human clinical sources. J Med Microbiol. 2008;57:570-580.
19. Font C, Cruceta A, Moreno A, Miro O, Coll-Vinent B, Almela M, Mensa J. EA study of 30 patients with bacteremia due to Campylobacter spp. Med Clin (Barc). 1997;108:336-340.
20. Francioli P, Herzstein J, Grob JP, Vallotton JJ, Mombelli G, Glauser MP. Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med. 1985;145:289-292.
21. Freeman AF, Holland SM. Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol. 2007;10:70-75.
22. Galanis E. Campylobacter and bacterial gastroenteritis. CMAJ. 2007;177:570-571.
23. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16:128-140.
24. Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun-Buisson C, Lesprit P. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis. 2008;27:185-189.
25. Guerrant RL, Lahita RG, Winn WC Jr, Roberts RB. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med. 1978;65:584-592.
26. Hagensee ME, Benyunes M, Miller JA, Spach DH. Campylobacter jejuni bacteremia and Guillain-Barre syndrome in a patient with GVHD after allogeneic BMT. Bone Marrow Transplant. 1994;13: 349-351.
27. Heng AE, De Champs C, Souweine B, Guy L, Sirot J, Deteix P. Campylobacter fetus bacteraemia in a renal graft recipient. Nephrol Dial Transplant. 2002;17:689-690.
28. Jackson CJ, Fox AJ, Wareing DR, Sutcliffe EM, Jones DM. Genotype analysis of human blood isolates of Campylobacter jejuni in England and Wales. Epidemiol Infect. 1997;118:81-89.
29. Knobel H, Lopez-Colomes J, Saballs P, Drobnic L. EUnusual forms of bacteremia due to Campylobacter jejuni in patients with HIV infection. Med Clin (Barc). 1994;103:239.
30. Kulkarni SP, Lever S, Logan JM, Lawson AJ, Stanley J, Shafi MS. Detection of campylobacter species: a comparison of culture and polymerase chain reaction based methods. J Clin Pathol. 2002;55: 749-753.
31. Lau SK, Woo PC, Leung KW, Yuen KY. Emergence of cotrimoxazole-and quinolone-resistant Campylobacter infections in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis. 2002;21:127-129.
32. Lu PL, Hsueh PR, Hung CC, Chang SC, Luh KT, Lee CY. Bacteremia due to Campylobacter species: high rate of resistance to macrolide and quinolone antibiotics. J Formos Med Assoc. 2000; 99:612-617.
33. Maccario M, Tarantino A, Nobile-Orazio E, Ponticelli C. Campylobacter jejuni bacteremia and Guillain-Barre syndrome in a renal transplant recipient. Transpl Int. 1998;11:439-442.
34. Maher M, Finnegan C, Collins E, Ward B, Carroll C, Cormican M. Evaluation of culture methods and a DNA probe-based PCR assay for detection of Campylobacter species in clinical specimens of feces. J Clin Microbiol. 2003;41:2980-2986.
35. Manfredi R. [Effects of the introduction of highly active antiretroviral therapy (HAART) on the temporal trend of diagnosis of AIDS and AIDS-defining disorders]. Infez Med. 2000;8:134-138.
36. Manfredi R, Calza L, Chiodo F. Enteric and disseminated Campylobacter species infection during HIV disease: a persisting but significantly modified association in the HAART era. Am J Gastroenterol. 2002;97:510-511.
37. Manfredi R, Nanetti A, Ferri M, Chiodo F Fatal Campylobacter jejuni bacteraemia in patients with AIDS. J Med Microbiol. 1999;48: 601-603.
38. Melero JM, Freitag SK, Perazzi BE, Vay CA, Famiglietti A. [Campylobacter jejuni bacteremia in a patient with non Hodgkin lymphoma and pneumonia]. Medicina (B Aires). 2000;60:407-408.
39. Miller WG, On SL, Wang G, Fontanoz S, Lastovica AJ, Mandrell RE. Extended multilocus sequence typing system for Campylobacter coli, C. lari, C. upsaliensis, and C. helveticus. J Clin Microbiol. 2005;43: 2315-2329.
40. Monno R, Rendina M, Ceci G, Rizzo C, Luzzi I, Francavilla A, Rizzo G, Ierardi E. Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of the literature. New Microbiol. 2004;27:281-285.
41. Morrison VA, Lloyd BK, Chia JK, Tuazon CU. Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis. 1990;12:387-392.
42. Murakami H, Goto M, Ono E, Sawabe E, Iwata M, Okuzumi K, Yamaguchi K, Takahashi T. Isolation of Helicobacter cinaedi from blood of an immunocompromised patient in Japan. J Infect Chemother. 2003;9:344-347
43. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. 6th ed. Washington DC: ASM Press; 1995.
44. Nathwani D, Morris AJ, Smith CC. Simultaneous Streptococcus pneumoniae, Giardia lamblia and Campylobacter pylori infection: an adult presentation of X-linked hypogammaglobulinaemia. Scott Med J. 1989;34:502.
45. National Prevalence Survey of Hospital Acquired Infections: definitions. A preliminary report of the steering group of the Second National Prevalence Survey. J Hosp Infect. 1993;24: 69-76.
46. Neuzil KM, Wang E, Haas DW, Blaser MJ. Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies. J Clin Microbiol. 1994;32:1718-1720.
47. Nielsen H, Hansen KK, Gradel KO, Kristensen B, Ejlertsen T, Ostergaard C, Schonheyder HC. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect. 2010;16:57-61.
48. Ozaki M, Murase T, Park JW, Aoki M, Kawato M. [Campylobacter fetus bacteremia and thrombophlebitis in a patient with Waldenstrom's macroglobulinemia]. Kansenshogaku Zasshi. 1999;73:86-89.
49. Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM, Meynard JL. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008;47:790-796.
50. Perlman DM, Ampel NM, Schifman RB, Cohn DL, Patton CM, Aguirre ML, Wang WL, Blaser MJ. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann Intern Med. 1988;108:540-546.
51. Pigrau C, Almirante B, Bartolome R, Pahissa A. [Bacteremia due to Campylobacter sp. in patients with HIV infection]. Med Clin (Barc). 1994;103:239.
52. Pigrau C, Almirante B, Pahissa A, Bartolome R. Campylobacter spp. bacteremia in AIDS patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:93-95.
53. Pigrau C, Bartolome R, Almirante B, Planes AM, Gavalda J, Pahissa A. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis. 1997;25: 1414-1420.
54. Reed RP, Friedland IR, Wegerhoff FO, Khoosal M. Campylobacter bacteremia in children. Pediatr Infect Dis J. 1996;15:345-348.
55. Sakran W, Raz R, Levi Y, Colodner R, Koren A. Campylobacter bacteremia and pneumonia in two splenectomized patients. Eur J Clin Microbiol Infect Dis. 1999;18:496-498.
56. Sanchez R, Fernandez-Baca V, Diaz MD, Munoz P, Rodriguez-Creixems M, Bouza E. Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother. 1994;38:1879-1882.
57. Sanz-Garcia M, Fernandez-Cruz A, Rodriguez-Creixems M, Cercenado E, Marin M, Munoz P, Bouza E. Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors. Medicine (Baltimore). 2009;88:77-82.
58. Schonheyder HC, Sogaard P, Frederiksen W. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994. Scand J Infect Dis. 1995;27:145-148.
59. Schuster M, Blaser MJ, Nachamkin I. Serendipitous detection of persistent Campylobacter jejuni subspecies jejuni bacteremia in a patient undergoing bone marrow transplantation. Clin Infect Dis. 1997;24:1270.
60. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J. Campylobacter bacteraemia in England and Wales, 1981-1991. Epidemiol Infect. 1993; 110:567-573.
61. Sorvillo FJ, Lieb LE, Waterman SH. Incidence of campylobacteriosis among patients with AIDS in Los Angeles County. J Acquir Immune Defic Syndr. 1991;4:598-602.
62. Targan SR, Chow AW, Guze LB. Campylobacter fetus associated with pulmonary abscess and empyema. Chest. 1977;71:105-108.
63. Tauxe RV, Pegues DA, Hargrett-Bean N. Campylobacter infections: the emerging national pattern. Am J Public Health. 1987;77:1219-1221.
64. Tee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis. 1998;26:91-96.
65. Tilse MH, McAlister TV. Isolation of Campylobacter fetus from blood cultures. Med J Aust. 1981;2:337-338.
66. Vandamme P, Falsen E, Rossau R, Hoste B, Segers P, Tytgat R, De Ley J. Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol. 1991;41:88-103.
67. Van der Hilst JC, Smits BW, van der Meer JW. Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth J Med. 2002;60:140-147.
68. van der Meer JW, Mouton RP, Daha MR, Schuurman RK. Campylobacter jejuni bacteraemia as a cause of recurrent fever in a patient with hypogammaglobulinaemia. J Infect. 1986;12: 235-239.
69. Van Der Meer JW, Zegers BJ. Agammaglobulinaemia. Neth J Med. 1994;45:250-256.
70. Zylberman M, Demonty G, Menchaca A, Ferro L, Tokumoto MB. ECampylobacter fetus fetus and colon adenocarcinoma. Medicina (B Aires). 2000;60:665-666.